‌

US Patent 9919032 Method for administering a sustained release formulation

Patent 9919032 was granted and assigned to Phasebio Pharmaceuticals, Inc. on March, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Phasebio Pharmaceuticals, Inc.

0

Current Assignee

Phasebio Pharmaceuticals, Inc.

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Susan Arnold0

Christopher Prior0

Lynne Georgopoulos0

Date of Patent

March 20, 2018

0

Patent Application Number

153553860

Date Filed

November 18, 2016

0

Patent Primary Examiner

0

Patent abstract

The present invention provides pharmaceutical formulations for sustained release when administered at cold temperatures, and methods for delivering a treatment regimen with a combination of sustained release and long half-life formulations. The invention provides improved pharmacokinetics for peptide and small molecule drugs.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9919032 Method for administering a sustained release formulation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.